EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)

Clinical trials for EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC) explained in plain language.

Never miss a new study

Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC) trials appear

Sign up with your email to follow new studies for EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 9 Not yet recruiting 2 Not yet finished but already full! 1

New cancer drug IDE161 enters human testing

Disease control Ongoing

This early-stage trial tests a new drug called IDE161, alone or with the immunotherapy pembrolizumab, in 216 adults with advanced solid tumors (like breast, ovarian, or lung cancer). The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. It i…

Matched conditions: EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)

Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control

Last updated Jun 23, 2026 12:00 UTC

EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)

Get alerted when new EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC) trials appear

New cancer drug IDE161 enters human testing